|

Gla-100 (insulin glargine) Clinical Trials

1 actively recruiting trial

Also known as: LANTUS®

Pipeline

Phase 4: 1

Top Sponsors

  • Sanofi1

Indications

  • Type 2 Diabetes (T2D)1
  • Diabetes1

Other1 trial

iGlarLixi CGM Study in Chinese T2D Individuals After OADs
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.